References
<A NAME="RG04104ST-1A">1a</A>
Bicker UW. In
Immune Modulation Agents and their Mechanisms
Fenical RG.
Chirigos MA.
Marcel Dekker;
New York and Basel:
1984.
p.447
<A NAME="RG04104ST-1B">1b</A>
Iyengar BS.
Dorr RT.
Alberts DS.
Hersh EM.
Salmon SE.
Remers WA.
J. Med. Chem.
1999,
42:
510
<A NAME="RG04104ST-2">2</A>
Iyengar BS.
Dorr RT.
Remers WA.
J. Med. Chem.
2004,
47:
218
<A NAME="RG04104ST-3A">3a</A>
Remers W, and
Iyengar B. inventors; US 6476236.
; Chem. Abstr. 2002, 137, 337772
<A NAME="RG04104ST-3B">3b</A>
Lopez-Berestein G,
Remers WA, and
Hersh EM. inventors; PCT Int. Appl. 2002041871.
; Chem. Abstr. 2002, 137, 10970
<A NAME="RG04104ST-3C">3c</A>
Kitagawa S,
Minafuji M, and
Yokoi T. inventors; Jpn. Kokai Tokkyo Koho JP 61140561.
; Chem. Abstr. 1987, 106, 50009
<A NAME="RG04104ST-3D">3d</A>
Bosies E,
Berger H,
Kampe W,
Bicker U, and
Grafe A. inventors; US 4410532.
; Chem. Abstr. 1984, 100, 68151
<A NAME="RG04104ST-3E">3e</A>
Berger H,
Gall R,
Kampe W,
Bicker U, and
Kuhn R. inventors; Ger. Offen DE 2948832.
; Chem. Abstr. 1981, 95, 115257
<A NAME="RG04104ST-4">4</A>
Boukhris S.
Souizi A.
Tetrahedron Lett.
2003,
44:
3259
<A NAME="RG04104ST-5A">5a</A>
Tanner D.
Angew. Chem., Int. Ed. Engl.
1994,
33:
599
<A NAME="RG04104ST-5B">5b</A>
Li A.-H.
Dai L.-X.
Aggarwal VK.
Chem. Rev.
1997,
97:
2341
<A NAME="RG04104ST-5C">5c</A>
Stamm H.
J. Prakt. Chem.
1999,
4:
319
<A NAME="RG04104ST-5D">5d</A>
Atkinson RS.
Tetrahedron
1999,
55:
1519
<A NAME="RG04104ST-5E">5e</A>
McCoull W.
Davis FA.
Synthesis
2000,
1347
<A NAME="RG04104ST-5F">5f</A>
Sweeney JB.
Chem. Soc. Rev.
2002,
31:
247
<A NAME="RG04104ST-6A">6a</A>
Goodridge TH.
Huntress WT.
Bratzell RP.
Cancer Chemother. Rep.
1963,
26:
341
<A NAME="RG04104ST-6B">6b</A>
Dermer OC.
Ham GE.
Ethyleneimine and other Aziridines
Academic Press;
New York and London:
1969.
p.425
<A NAME="RG04104ST-7A">7a</A>
Dauban P.
Dodd RH.
Tetrahedron Lett.
1998,
39:
5739
<A NAME="RG04104ST-7B">7b</A>
Schirmeister T.
Peric M.
Bioorg. Med. Chem.
2000,
8:
1281
<A NAME="RG04104ST-8A">8a</A>
Fioravanti S.
Morreale A.
Pellacani L.
Tardella PA.
Synthesis
2001,
1975
<A NAME="RG04104ST-8B">8b</A>
Fioravanti S.
Morreale A.
Pellacani L.
Tardella PA.
J. Org. Chem.
2002,
67:
4972
<A NAME="RG04104ST-8C">8c</A>
Colantoni D.
Fioravanti S.
Pellacani L.
Tardella PA.
Org. Lett.
2004,
6:
197
<A NAME="RG04104ST-9">9</A>
Texier-Boullet F.
Foucaud A.
Tetrahedron Lett.
1982,
23:
4927
<A NAME="RG04104ST-10">10</A>
Lwowski W.
Maricich TJ.
J. Am. Chem. Soc.
1965,
87:
3630
<A NAME="RG04104ST-11">11</A>
Typical Experimental Procedure: All compounds were synthesized with a Carousel Reaction Station from Radleys Discovery
Technologies (UK). The synthesis involved the following sequential steps. To the stirred
solutions of 2.0 mmol of ethyl cyanoacetate or malononitrile in CH2Cl2, 2.4 mmol of aldehyde and 1.0 g of basic Al2O3 were added. Upon completion, reaction mixtures were filtered. To the so obtained
unsaturated nitriles in CH2Cl2, CaO and nosyloxycarbamates were added in the amounts reported in Table
[1]
and Table
[2]
. After completion (TLC), the crude aziridines were filtered through plugs filled
with silica gel using a 9:1 hexane/EtOAc mixture and obtained as pale yellow oils
after solvent removal. Selected spectral data of new compounds. Compound 2a: IR (CCl4): 2253, 1761, 1731 cm-1. 1H NMR (300 MHz, CDCl3): δ = 1.13 (t, J = 7.2 Hz, 3 H), 1.24 (t, J = 7.2 Hz, 3 H), 1.34 (t, J = 7.2 Hz, 3 H), 1.68-1.82 (m, 2 H), 3.08 (t, J = 6.6 Hz, 1 H), 4.09-4.23 (m, 2 H), 4.23-4.45 (m, 2 H). 13C NMR (75 MHz, CDCl3): δ = 10.4, 14.0, 14.2, 23.3, 38.6, 51.3, 63.4, 64.1, 113.3, 157.2, 162.6. GC/MS:
m/z (%) = 240 (9) [M+], 114 (24), 95 (46), 94 (12), 68 (100), 67 (10). HRMS (ES Q-TOF) calcd for C11H17N2O4 (M + H)+: 241.1188; found: 241.1200. Compound 2k: IR (CCl4): 2253, 1756 cm-1. 1H NMR (200 MHz, CDCl3): δ = 1.18 (t, J = 7.3 Hz, 3 H), 1.35 (t, J = 7.3 Hz, 3 H), 1.66-1.89 (m, 2 H), 3.19 (t, J = 6.6 Hz, 1 H), 4.22-4.48 (m, 2 H). 13C NMR (50 MHz, CDCl3): δ = 9.9, 14.0, 23.1, 25.0, 52.4, 64.9, 110.3, 110.8, 156.2. GC/MS: m/z (%) = 193 (3) [M+], 121 (21), 94 (100), 93 (53), 83 (10), 68 (15), 67 (75), 66 (38), 65 (10), 56 (23),
54 (11). HRMS (ES Q-TOF) calcd for C9H12N3O2 (M + H)+: 194.0930; found: 194.0927.
<A NAME="RG04104ST-12">12</A>
Lwowski W.
In Nitrenes
Lwowski W.
John Wiley and Sons;
New York:
1970.
Chap. 6.
<A NAME="RG04104ST-13">13</A>
Fioravanti S.
Morreale A.
Pellacani L.
Tardella PA.
Eur. J. Org. Chem.
2003,
4549
<A NAME="RG04104ST-14A">14a</A>
Banks MR.
Cadogan JIG.
Gosney I.
Hodgson PKG.
Langridge-Smith PRR.
Millar JRA.
Taylor AT.
J. Chem. Soc., Chem. Commun.
1995,
885
<A NAME="RG04104ST-14B">14b</A> N-Boc-protected O-sulfonyl hydroxylamine showed no predictable reactivity, see ref.13 and:
Fioravanti S.
Marchetti F.
Morreale A.
Pellacani L.
Tardella PA.
Org. Lett.
2003,
5:
1019
<A NAME="RG04104ST-15">15</A>
9-Fluorenylmethyl nosyloxycarbamate (NsONHFmoc) was synthesized in 80% yield, starting
from commercial 9-fluorenylmethyl N-hydroxycarbamate (HONHFmoc) and nosyl chloride following the standard procedure,
see ref.10
<A NAME="RG04104ST-16A">16a</A>
De Kimpe N.
Sulmon P.
Verhé R.
De Buyck L.
Schamp N.
J. Org. Chem.
1983,
48:
4320
<A NAME="RG04104ST-16B">16b</A>
Charrier J.
Foucaud A.
Person H.
Loukakou E.
J. Org. Chem.
1983,
48:
481